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Why lymph nodes grow
At the initiation of an immune response, lymph nodes can double in size 
in a day and can be ten times their original size in five to seven days. 
Webster and colleagues report on page 1903 that dendritic cells, quite 
distinct from their function in antigen presentation, stimulate endothelial 
cell proliferation and vascular growth in the growing lymph node.
Peripheral challenge (such as immunization) induces dendritic cells to 
mature and migrate to the lymph nodes. But what is their role once 
there? Dendritic cells are well known for their role in B and T cell lym-
phocyte stimulation but, surprisingly, Lu’s team found that without lym-
phocytes (in Rag−/− mice) dendritic cells could activate lymph node 
growth and endothelial cell proliferation almost as effectively.
Vascular endothelial growth factor (VEGF) has been implicated in 
lymph node growth, and the team found that dendritic cells could increase 
VEGF levels in the lymph node, again, without the need for lymphocytes. 
Increased VEGF and increased endothelial cell proliferation required 
dendritic cell–mediated recruitment of 
cells from the circulation. Either these re-
cruited cells or other lymph node cells 
(but not the dendritic cells) are then 
thought to produce the VEGF. Determin-
ing how VEGF levels are up-regulated is 
the subject of ongoing study.
Enlargement of the lymph nodes is a 
normal step in combating infection, but 
it also occurs during autoimmune re-
sponses. One possibility for combating 
lymph node growth during autoimmu-
nity is antiangiogenic drugs, which were 
developed to combat tumors. 
Is war necessary 
(for transplant success)?
If immune cells are an army, then a graft 
transplant is a foreign invasion. New work by 
Yu et al. on page 1851 shows that antigen-
presenting cells (APCs) from the graft are 
rapidly killed by the host’s first line of defense: 
natural killer (NK) cells. But far from hindering 
the chance of graft survival, this battle actually 
improves it.
NK cells are known to improve the chance of 
graft survival, but how they do this was unknown. 
Li’s team wanted to know what happens to graft 
APCs when NK cells are absent.
Using mice that lacked a full-blown rejec-
tion response (because they lacked lympho-
cytes), the team were able to follow the fate of 
donor APCs for longer than would normally 
be possible. They found that in the absence of 
NK cells, donor APCs could roam free in the 
host, as confirmed by their presence in spleen, 
liver, and lung. In the presence of NK cells, 
however, injected or graft-derived APCs 
were completely eliminated from the host.
The team reasoned that immediate de-
struction of the APCs by NK cells was pre-
venting a more vigorous anti-APC response 
by host lymphocytes. To confirm this, they 
restored the T lymphocyte population of the 
mice and showed that, in the absence of NK 
cells, APCs activated robust and persistent T 
cell proliferation and IFN-γ production—
marks of a ferocious immune response. But in 
the presence of NK cells this T cell activation 
was, as predicted, markedly reduced.
The daily immunosuppressants that trans-
plant patients must take “are designed to 
suppress T cells,” says lead researcher Xian Li, 
“but we don’t know if they are also suppressing 
NK cells.” Drugs that specifically suppress T cells 
but boost host NK cells might therefore im-
prove the outcome for transplant patients. 
Don’t overreact
Response to microbial infection must be perfectly balanced to kill off the 
bugs but not the surrounding host tissue. Wirtz et al. (page 1875) report that 
in sepsis this balance fails. By attempting to prevent an overzealous innate 
immune response, the cytokine IL-27 prevents efficient bacterial clearance.
IL-27 is strongly induced by microbial stimuli in vitro, but its response to 
microbes in vivo was unclear. In a mouse model of septic peritonitis, microbial 
invasion from the gut triggered IL-27 production. IL-27 was produced earlier 
than cytokines of the adaptive immune response, IL-12 and IL-23, indicating 
that IL-27 induction was, in this case, part of the innate response.
In earlier studies, IL-27 was shown to promote T cell proliferation and 
thus positively regulate adaptive immunity. In the present study, however, 
IL-27 displayed a negative effect on the innate response: mice lacking 
functional IL-27 cleared bacteria more efficiently and were more likely to 
survive than their wild-type counterparts. The authors attribute this 
increased survival to a corresponding increase in the number and the 
oxidative burst activity of granulocytes found in the abdomen.
How IL-27 suppresses myeloid cell activation remains to be determined. 
Furthermore, “the normal physiological role [of IL-27] is still unclear,” says 
Wirtz. Its role in innate immunity, at least, is probably to limit inflammation 
and thus protect body tissues from damage. In the case of sepsis, however, 
this control goes too far. 
Dendritic cells prompt 
endothelial cells (blue) 
to proliferate (pink) during 
an immune response.
Long-term survival of a transplant is improved in 
the presence of NK cells.
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